<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">307419</id>
  <title nil="true"/>
  <common-name>4-[[6-(4-methylsulfonylphenyl)imidazo[2,1-b][1,3]thiazol-5-yl]methyl]morpholine</common-name>
  <description>4-[[6-(4-methylsulfonylphenyl)imidazo[2,1-b][1,3]thiazol-5-yl]methyl]morpholine belongs to the imidazoles, a subclass of azoles within the organic compounds. It is an organoheterocyclic compound with the formula C17H19N3O3S2 and an average molecular weight of 377.50 g/mol.</description>
  <cas>3415-16-5</cas>
  <pubchem-id>201228</pubchem-id>
  <chemical-formula>C17H19N3O3S2</chemical-formula>
  <weight>377.5</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-29T01:32:37Z</created-at>
  <updated-at type="dateTime">2026-08-29T01:32:37Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CS(=O)(=O)C1=CC=C(C=C1)C2=C(N3C=CSC3=N2)CN4CCOCC4</moldb-smiles>
  <moldb-formula>C17H19N3O3S2</moldb-formula>
  <moldb-inchi>InChI=1S/C17H19N3O3S2/c1-25(21,22)14-4-2-13(3-5-14)16-15(12-19-6-9-23-10-7-19)20-8-11-24-17(20)18-16/h2-5,8,11H,6-7,9-10,12H2,1H3</moldb-inchi>
  <moldb-inchikey>NVDWZHWMMDGUED-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">377.0867838</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>2.3</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM303312</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>4-[[6-(4-methylsulfonylphenyl)imidazo[2,1-b][1,3]thiazol-5-yl]methyl]morpholine</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Azoles</klass>
  <subklass>Imidazoles</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0258465</sync-id>
  <structure-inchikey>NVDWZHWMMDGUED-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>20000040000000000840000800000000000000000000000000000000000000000000000000001100000020000002000000000000000000000010000000080001080000000000000000000000000000020800010000800001000000000000000008000000000000000000000000100800002020100020000000000000000000000000040000000000400000000000000800000080000000000000000000008000000000000000001000000080000040000000040000000088001000000000000000001000000000000000000000000100000000000000000000200040000010000000000000041000040000000000400000000000040000000000040000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAZAAAAHAAAAIABBgBgAAAAAQMQACAAAAAG
CAAoAAAAAwIIACgAAAADAgZAKAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMBBkAo
AAAAAwQGQGgAAAADAwEGQGgAAAADAwEGQCgAAAADBAZAKAAAAAMEB0AoAAAA
AwMGQGgAAAADAwEGQGgAAAADAwEQQCgAAAADAgZAKAAAAAMEB0AoAAAAAwMG
AGAAAAACAgcAIAAAAAMGAGAAAAACAgYAYAAAAAICCAAgAAAAAgYAYAAAAAIC
BgBgAAAAAgILAAEAAQIIAgEDCAIBBAAEBWgMBQZoDAYHaAwHCGgMCAloDAcK
IAoLaAwLDGgMDA1oDA0OaAwOD2gMDxBoDBARaAwLEgASEwATFAAUFQAVFgAW
FwAXGAAJBGgMEQpoDBAMaAwYEwBCBAAAAAYECQgHBgUFDQwQDw4FERAMCwoG
FBUWFxgTFwQAAAAAAAAAFg==
</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:15:36Z</structure-indexed-at>
</compound>
